|
COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 2,1999 PSA#2274National Cancer Institute, Research Contracts Branch, PCPSS, Executive
Plaza South, Room 635, Bethesda, Md 20892 A -- PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS AND THEIR
MODULATION BY CHEMOPREVENTIVE AGENTS (RFPNCI-CN-85052-72) SOL MAA
RFP-NCI-CN-95021-72 DUE 020199 POC Jacqueline Ballard, Contracting
Officer, 301-435-3795 WEB: http://rcb.nci.nih.gov/rfp.htm.,
http://rcb.nci.nih.gov/rfp.htm.. E-MAIL: ballardj@mail.nih.gov,
ballardj@mail.nih.gov. SEMI ANNUAL MASTER AGREEMENT ANNOUNCEMENT
RFP-NCI-CN-95021-72 Preclinical Evaluation of Intermediate Endpoints
and their Modulation by Chemopreventive Agents (RFP NCI-CN-85052-72)
RFP Issue : (ELECTRONIC RFP ANNOUNCEMENT: POTENTIAL OFFERORS WILL BE
RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICITATION AND
AMENDMENTS.) Proposals Due : February 1, 1999 The Division of Cancer
Prevention (DCP), National Cancer Institute (NCI), National Institutes
of Health (NIH), intends to expand the existing Master Agreement (MA)
pool for "Preclinical Evaluation of Intermediate Endpoints and Their
Modulation by Chemopreventive Agents". ALL MA HOLDERS ALREADY IN THE
EXISTING MA POOL NEED NOT RESPOND TO THIS ANNOUNCEMENT. Offerors
selected for award of a MA may be solicited to provide qualified
personnel, materials and supplies, equipment and facilities to carry
out orders issued. Offerors should be capable of performing animal
cancer model studies of biomarkers and intermediate endpoints that
might be used in human clinical trials in order to examine in detail
the biomarker modulating effects of selected chemopreventive compounds.
The emphasis will be on efficient studies aimed at providing more
quantitative and more validated intermediate endpoints for future human
clinical trials. Individual work requirements (Master Agreement Orders
(MAOs) ) will be issued during the period of performance and awarded
based upon competition among members of the MA Pool. The MA mechanism
is a pre-qualification process to enable qualified sources to compete
for and perform future contracts which will be awarded based on Request
for Proposals (RFPs). The MA award is non-monetary and is exclusively
for the purpose of compiling a pool of contractors who are
pre-qualified to perform services for efficacy studies. The obligation
of funds shall be accomplished solely through the award of contracts
(MAO). Any MA awarded as a result of this solicitation will be in
effect from the effective date to December 31, 2002. This solicitation
willbe open for the duration of the existing MA Pool with due dates
for receipt for proposals semi-annually, August 1 and February 1 (or
the next business day) of each year. All responsible sources meeting
these criteria are encouraged to submit a proposal and a sample
requirement to be considered by the NCI. The RFP may be accessed
through the Research Contracts Branch Home Page by using the following
Internet address: http://rcb.nci.nih.gov/rfp.htm. It is the offeror's
responsibility to monitor the above internet site for the release of
this solicitation and amendments, if any. POTENTIAL OFFERORS WILL BE
RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICITATION AND
AMENDMENTS. (Hard copies will be available only upon individual
request). Point of contract: Jacqueline Ballard, Contracting Officer,
NCI, AMB, PCPSS; 6120 Executive Boulevard, Executive Plaza S., Room
635, Rockville, MD. 20852; Email address: ballardj@mail.nih.gov.; Fax
301-402-8597. No collect calls will be accepted. Posted 01/29/99
(W-SN292985). (0029) Loren Data Corp. http://www.ld.com (SYN# 0010 19990202\A-0010.SOL)
A - Research and Development Index Page
|
|